Health
Pfizer vaccine can neutralise coronavirus variants first reported in UK, South Africa: Study – Hindustan Times
The research, published in the journal Nature Medicine, noted that the vaccine is effective against coronavirus variants.
The Covid-19 vaccine co-developed by the American pharmaceutical giant Pfizer and the German biotechnology company BioNTech can neutralise variants of the novel coronavirus that were first reported in the UK and South Africa, a new study suggests.
The research, published in the journal Nature Medicine, noted that the vaccine is effective against coronavirus variants carrying the N501Y and E484K mutations.
According to the scientists, including those from the University of Texas in the US, these…
-
Noosa News18 hours agoYoung voices shape Sunshine Coast’s future
-
Business18 hours ago2 Low Cost Active ASX ETFs to consider
-
Noosa News17 hours agoQueensland government to review greenhouse gas emission reduction targets
-
Noosa News15 hours agoCopperString transmission line projected to cost almost $14b amid massive blowout